查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587272

低温运输药品市场：药品、服务、温度范围、运输 - 2025-2030 年全球预测

Cold-chain Pharma Market by Pharma Product (Biologics, Over-the-Counter Medicines, Prescribed Drugs), Services (Transportation, Warehousing & VAS), Temperature Range, Transportation - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年低温运输药品市场价值为78.9亿美元，预计到2024年将达到88.5亿美元，复合年增长率为12.65%，到2030年将达到181.8亿美元。

低温运输药品市场包括旨在将药品维持在特定低温下的物流、储存和运输系统。这种需求的根源在于维持温度敏感药物、疫苗和生技药品的有效性和品质。重要的应用包括疫苗分发、生物製药和临床试验材料，最终用户范围从医院到实验室再到零售药局。由于全球对生物製药和复杂生技药品的需求不断增加，以及对监管合规性和品质标准的日益关注，预计该市场将大幅成长。慢性病盛行率的上升和全球疫苗接种的推动，以及支援即时资料追踪和预测分析的物联网和人工智慧监控系统的技术进步，对这一增长做出了重大贡献。然而，该行业面临营运成本高、发展中地区基础设施有限以及严格的监管环境等限制，为无缝扩张带来了挑战。

主要市场统计
基准年[2023] 78.9亿美元
预测年份 [2024] 88.5亿美元
预测年份 [2030] 181.8亿美元
复合年增长率（%） 12.65%

在扩大新兴市场的低温运输基础设施以及开拓更永续和节能的技术以最大限度地减少碳足迹方面存在着巨大的机会。生物感测包装和基于区块链的可追溯性解决方案还有创新空间，可以提高供应链的透明度和安全性。市场相关人员还应该探索人工智慧和机器学习的进步，以进行预测性维护和路线优化，以降低物流成本。挑战包括解决熟练劳动力的差距，适应快速的技术创新，同时确保品质和安全合规性。行业参与者应投资于培训和发展计划，并与高科技公司建立伙伴关係，以利用下一代技术。透过专注于稳健、适应性强的策略和永续实践，公司可以利用新兴机会并巩固其市场定位。不断探索环保材料和经济高效、扩充性的解决方案可以确保在这个动态环境中的弹性和竞争力。

市场动态：揭示快速发展的低温运输药品市场的关键市场洞察

供需的动态交互作用正在改变低温运输药品市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对温度敏感的药品和产品的储存需求增加
    • 政府对药品储存和运输的严格规定
    • 政府加大对研发活动的承诺
  • 市场限制因素
    • 冷库建置及维护成本高
  • 市场机会
    • 疫苗开发、单株抗体和生技药品的进展
    • 将物联网和区块链融入药品低温运输
  • 市场挑战
    • 医药低温运输物流运作复杂且缺乏熟练的专业人员

波特五力：驾驭低温运输医药市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解低温运输药品市场的外部影响

外部宏观环境因素对低温运输医药市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解低温运输药品市场竞争状况

对低温运输药品市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV低温运输药品市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估低温运输药品市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製低温运输药品市场的成功之路

低温运输药品市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对温度敏感的药品和产品的储存需求增加
      • 政府对药品储存和运输的严格规定
      • 加强政府对研发活动的承诺
    • 抑制因素
      • 冷藏保管区域的实施和维护成本较高
    • 机会
      • 疫苗开发、单株抗体和生技药品的进展
      • 将物联网和区块链融入药品低温运输
    • 任务
      • 医药低温运输物流运作复杂且缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章低温运输药品市场药品

  • 生物製药
  • 非处方药
  • 处方药
  • 原料药药

第七章低温运输药品市场：依服务分类

  • 运输
  • 仓库管理和加值服务

第八章以温度范围分類的低温运输药品市场

  • 常温
  • 冷藏
    • 冷冻的
    • 液相液态液态氮条件
    • 超级冷冻
    • 气相液态氮

第九章 药品低温运输市场运输

  • 航路
  • 路
  • 航道

第十章美洲低温运输药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太低温运输药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲低温运输药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S
  • AmerisourceBergen Corporation
  • Cavalier Logistics, Inc. by Mitsubishi Logistics
  • Continental AG
  • CWT Ltd.
  • DB Schenker
  • Deutsche Post AG
  • DHL International GmbH
  • FedEx Corporation
  • HCL Technologies Limited
  • Helapet ltd.
  • JWD InfoLogistics Public Co. Ltd.
  • Keppel Telecommunications & Transportation Ltd,
  • Kerry Logistics Network Limited by SF Holding Co., Ltd.
  • Kuehne+Nagel Management AG
  • OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
  • SCG Logistics Management Co Ltd.
  • Tiong Nam Logistics Holdings Berhad
  • United Parcel Service, Inc.
  • VersaCold Logistics Services
  • WHA Group
  • Ych Group
  • Yusen Logistics Group
Product Code: MRR-7E6E70985BD9

The Cold-chain Pharma Market was valued at USD 7.89 billion in 2023, expected to reach USD 8.85 billion in 2024, and is projected to grow at a CAGR of 12.65%, to USD 18.18 billion by 2030.

The cold-chain pharma market encompasses the logistics, storage, and transportation systems designed to maintain pharmaceutical products at designated low temperatures. Its necessity is rooted in preserving the efficacy and quality of temperature-sensitive drugs, vaccines, and biologics. Critical applications include vaccine distribution, biopharmaceuticals, and clinical trial materials, with end-users ranging from hospitals to research labs and retail pharmacies. The market is forecasted for substantial growth driven by increased global demand for biopharmaceuticals and complex biologics, coupled with heightened attention to regulatory compliance and quality standards. The rising prevalence of chronic diseases and the global push for immunization contribute significantly to this growth, alongside technological advancements in IoT and AI-powered monitoring systems aiding real-time data tracking and predictive analytics. However, the sector faces limitations such as high operational costs, limited infrastructure in developing regions, and stringent regulatory landscapes, which pose challenges to seamless expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 7.89 billion
Estimated Year [2024] USD 8.85 billion
Forecast Year [2030] USD 18.18 billion
CAGR (%) 12.65%

A substantial opportunity lies in expanding the cold chain infrastructure in emerging markets and developing more sustainable, energy-efficient technologies to minimize carbon footprints. There is an opening for innovation in biosensing packaging and blockchain-based traceability solutions, offering enhanced supply chain transparency and security. Market players should also explore advancements in AI and machine learning for predictive maintenance and route optimization to reduce logistics costs. Challenges include addressing the gap in skilled workforce and adapting to rapid technological changes while ensuring quality and safety compliance. Industry participants should invest in training and development programs and foster partnerships with tech firms to leverage next-gen technologies. By focusing on robust, adaptable strategies and sustainable practices, businesses can capitalize on burgeoning opportunities to solidify market positioning. Continuous research into eco-friendly materials and cost-effective, scalable solutions will ensure resilience and competitiveness in this dynamic landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold-chain Pharma Market

The Cold-chain Pharma Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for storage of temperature-sensitive drugs and products
    • Stringent government regulations for pharmaceutical product storage and transportation
    • Increasing government initiatives for R&D activities
  • Market Restraints
    • High cost of execution for cold storage areas and maintenance
  • Market Opportunities
    • Advancement in vaccine development, monoclonal antibodies, and biologics
    • Integration of IoT and blockchain in pharma cold chain
  • Market Challenges
    • Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Cold-chain Pharma Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold-chain Pharma Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold-chain Pharma Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold-chain Pharma Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold-chain Pharma Market

A detailed market share analysis in the Cold-chain Pharma Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold-chain Pharma Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold-chain Pharma Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold-chain Pharma Market

A strategic analysis of the Cold-chain Pharma Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold-chain Pharma Market, highlighting leading vendors and their innovative profiles. These include AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S, AmerisourceBergen Corporation, Cavalier Logistics, Inc. by Mitsubishi Logistics, Continental AG, CWT Ltd., DB Schenker, Deutsche Post AG, DHL International GmbH, FedEx Corporation, HCL Technologies Limited, Helapet ltd., JWD InfoLogistics Public Co. Ltd., Keppel Telecommunications & Transportation Ltd,, Kerry Logistics Network Limited by SF Holding Co., Ltd., Kuehne + Nagel Management AG, OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited, SCG Logistics Management Co Ltd., Tiong Nam Logistics Holdings Berhad, United Parcel Service, Inc., VersaCold Logistics Services, WHA Group, Ych Group, and Yusen Logistics Group.

Market Segmentation & Coverage

This research report categorizes the Cold-chain Pharma Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Pharma Product, market is studied across Biologics, Over-the-Counter Medicines, Prescribed Drugs, and Raw Materials & Bulk Pharmaceuticals.
  • Based on Services, market is studied across Transportation and Warehousing & VAS.
  • Based on Temperature Range, market is studied across Ambient and Refrigerated. The Refrigerated is further studied across Frozen, Liquid-Phase Liquid Nitrogen Conditions, Ultra-Frozen, and Vapour-Phase Liquid Nitrogen.
  • Based on Transportation, market is studied across Air-ways, Road, and Sea-Ways.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for storage of temperature-sensitive drugs and products
      • 5.1.1.2. Stringent government regulations for pharmaceutical product storage and transportation
      • 5.1.1.3. Increasing government initiatives for R&D activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of execution for cold storage areas and maintenance
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in vaccine development, monoclonal antibodies, and biologics
      • 5.1.3.2. Integration of IoT and blockchain in pharma cold chain
    • 5.1.4. Challenges
      • 5.1.4.1. Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cold-chain Pharma Market, by Pharma Product

  • 6.1. Introduction
  • 6.2. Biologics
  • 6.3. Over-the-Counter Medicines
  • 6.4. Prescribed Drugs
  • 6.5. Raw Materials & Bulk Pharmaceuticals

7. Cold-chain Pharma Market, by Services

  • 7.1. Introduction
  • 7.2. Transportation
  • 7.3. Warehousing & VAS

8. Cold-chain Pharma Market, by Temperature Range

  • 8.1. Introduction
  • 8.2. Ambient
  • 8.3. Refrigerated
    • 8.3.1. Frozen
    • 8.3.2. Liquid-Phase Liquid Nitrogen Conditions
    • 8.3.3. Ultra-Frozen
    • 8.3.4. Vapour-Phase Liquid Nitrogen

9. Cold-chain Pharma Market, by Transportation

  • 9.1. Introduction
  • 9.2. Air-ways
  • 9.3. Road
  • 9.4. Sea-Ways

10. Americas Cold-chain Pharma Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cold-chain Pharma Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cold-chain Pharma Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S
  • 2. AmerisourceBergen Corporation
  • 3. Cavalier Logistics, Inc. by Mitsubishi Logistics
  • 4. Continental AG
  • 5. CWT Ltd.
  • 6. DB Schenker
  • 7. Deutsche Post AG
  • 8. DHL International GmbH
  • 9. FedEx Corporation
  • 10. HCL Technologies Limited
  • 11. Helapet ltd.
  • 12. JWD InfoLogistics Public Co. Ltd.
  • 13. Keppel Telecommunications & Transportation Ltd,
  • 14. Kerry Logistics Network Limited by SF Holding Co., Ltd.
  • 15. Kuehne + Nagel Management AG
  • 16. OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
  • 17. SCG Logistics Management Co Ltd.
  • 18. Tiong Nam Logistics Holdings Berhad
  • 19. United Parcel Service, Inc.
  • 20. VersaCold Logistics Services
  • 21. WHA Group
  • 22. Ych Group
  • 23. Yusen Logistics Group

LIST OF FIGURES

  • FIGURE 1. COLD-CHAIN PHARMA MARKET RESEARCH PROCESS
  • FIGURE 2. COLD-CHAIN PHARMA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLD-CHAIN PHARMA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COLD-CHAIN PHARMA MARKET DYNAMICS
  • TABLE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY OVER-THE-COUNTER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PRESCRIBED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RAW MATERIALS & BULK PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY WAREHOUSING & VAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AMBIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LIQUID-PHASE LIQUID NITROGEN CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULTRA-FROZEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VAPOUR-PHASE LIQUID NITROGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AIR-WAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ROAD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SEA-WAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 236. COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2023